Lilly and Hims & Hers expand access to FDA-approved Lilly medicines
The agreement lets eligible patients receive prescriptions for Zepbound (tirzepatide) and Foundayo (orforglipron) through the Hims & Hers platform at self-pay prices of $299 and $149 per month, respectively. Patients can complete a consultation, receive a prescription, and have the medication shipped directly to their home.
Primary source
Company press release (PR Newswire), November 6, 2026
Lilly and Hims & Hers expand access to FDA-approved Lilly medicines
Read the source: Lilly and Hims & Hers expand access to FDA-approved Lilly medicines prnewswire.com
Machine-summarized from the source above; not independently reported. How we use automation